Douglas Chee
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Liver Disease and Transplantation 2
- Liver Diseases and Immunity 1
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 10
- Co-authors
- Cheng Han Ng (13 shared papers)Mark Dhinesh Muthiah (13 shared papers)Kai En Chan (8 shared papers)Mazen Noureddin (10 shared papers)Nicholas Chew (6 shared papers)Rebecca Wenling Zeng (7 shared papers)Nicholas L. X. Syn (5 shared papers)Nobuharu Tamaki (2 shared papers)
- Journals
- Clinical Gastroenterology and Hepatology (3 papers)Alimentary Pharmacology & Therapeutics (2 papers)Canadian Journal of Cardiology (1 paper)Journal of Clinical Medicine (1 paper)Hepatology Communications (1 paper)
- Partner nations
- SingaporeUnited StatesJapan
In The Last Decade
Douglas Chee
19 papers receiving 572 citations
Douglas Chee's Hit Papers
Peers
Comparison fields: 5 of 48
- Hepatology 95
- Epidemiology 342
- Endocrinology, Diabetes and Metabolism 55
- Oncology 44
- Pathology and Forensic Medicine 29
Countries citing papers authored by Douglas Chee
This map shows the geographic impact of Douglas Chee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Chee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Chee more than expected).
Fields of papers citing papers by Douglas Chee
This network shows the impact of papers produced by Douglas Chee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Chee. The network helps show where Douglas Chee may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas Chee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis Hit paper breakdown → | 2023 | 242 |
| 2 | 2023 | 70 | |
| 3 | 2023 | 65 | |
| 4 | 2024 | 34 | |
| 5 | 2022 | 33 | |
| 6 | 2022 | 27 | |
| 7 | 2023 | 27 | |
| 8 | 2024 | 17 | |
| 9 | 2022 | 15 | |
| 10 | 2023 | 14 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 8 | |
| 13 | 2023 | 5 | |
| 14 | 2024 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2022 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 2 |
About Douglas Chee
Douglas Chee is a scholar working on Hepatology, Epidemiology, Pathology and Forensic Medicine, Cancer Research and Surgery, having authored 19 papers that have together received 584 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Alcohol Consumption and Health Effects (2 papers), Organ Transplantation Techniques and Outcomes (2 papers), Liver Disease and Transplantation (2 papers), Metabolism, Diabetes, and Cancer (1 paper), Liver Diseases and Immunity (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Hepatology (95 citations), Epidemiology (342 citations), Endocrinology, Diabetes and Metabolism (55 citations), Oncology (44 citations) and Pathology and Forensic Medicine (29 citations). Douglas Chee has collaborated with scholars based in Singapore, United States and Japan. Frequent co-authors include Cheng Han Ng, Mark Dhinesh Muthiah, Kai En Chan, Mazen Noureddin, Nicholas Chew, Rebecca Wenling Zeng, Nicholas L. X. Syn, Nobuharu Tamaki, Darren Jun Hao Tan and Daniel Q. Huang. Their work appears in journals such as Clinical Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics, Canadian Journal of Cardiology, Journal of Clinical Medicine and Hepatology Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.